DANIEL DEAN: Open Payments
NPI 1689292203 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 76 payments from 17 companies in 2025. Trend: 2023 $618 · 2024 $969 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $286 |
| AstraZeneca Pharmaceuticals LP | 9 | $204 |
| Novo Nordisk Inc | 10 | $148 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| Lilly USA, LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: VRAYLAR, FANAPT, Wegovy, FARXIGA, MOUNJARO, CAPLYTA, QULIPTA, BREZTRI.
Industry payments across GA — which companies pay providers there.
